(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 9.48%130.74B | 11.04%86.34B | 14.73%42.14B | 21.27%166.62B | 26.52%119.42B | 32.65%77.76B | 34.28%36.73B | 31.24%137.4B | --94.39B | 20.94%58.62B |
Operating income | 9.48%130.74B | 11.04%86.34B | 14.73%42.14B | 21.27%166.62B | 26.52%119.42B | 32.65%77.76B | 34.28%36.73B | 31.24%137.4B | 94.39B | 20.94%58.62B |
Cost of sales | -5.37%-117.06B | -7.05%-77.86B | -10.87%-38.91B | -20.93%-153.94B | -26.09%-111.09B | -32.27%-72.73B | -35.54%-35.09B | -28.71%-127.3B | ---88.11B | -17.74%-54.99B |
Operating expenses | -5.37%-117.06B | -7.05%-77.86B | -10.87%-38.91B | -20.93%-153.94B | -26.09%-111.09B | -32.27%-72.73B | -35.54%-35.09B | -28.71%-127.3B | -88.11B | -17.74%-54.99B |
Gross profit | 64.24%13.68B | 68.67%8.48B | 97.54%3.23B | 25.58%12.68B | 32.57%8.33B | 38.39%5.03B | 11.93%1.64B | 74.61%10.1B | 6.28B | 105.40%3.63B |
Selling expenses | -12.49%-4.17B | -18.11%-2.78B | -23.64%-1.41B | -23.06%-5B | -28.56%-3.71B | -23.67%-2.35B | -20.04%-1.14B | -31.96%-4.06B | ---2.88B | -37.84%-1.9B |
Administrative expenses | -1.39%-2.52B | 0.72%-1.66B | 2.42%-869.53M | -6.21%-3.35B | -13.55%-2.48B | -28.54%-1.68B | -38.90%-891.12M | -10.11%-3.16B | ---2.19B | 13.87%-1.3B |
Research and development expenses | 1.30%-2.66B | 4.45%-1.74B | 4.57%-862.46M | -14.36%-3.57B | -20.65%-2.69B | -26.88%-1.82B | -21.53%-903.77M | -11.00%-3.12B | ---2.23B | -4.28%-1.44B |
Profit from asset sales | --88.8M | --88.8M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provision | 108.98%12.59M | 108.98%12.59M | ---- | 13.44%-251.56M | -57.67%-140.14M | -57.67%-140.14M | ---- | -86.46%-290.62M | ---88.89M | -210.97%-88.89M |
-Other impairment is provision | 108.98%12.59M | 108.98%12.59M | ---- | 13.44%-251.56M | -57.67%-140.14M | -57.67%-140.14M | ---- | -86.46%-290.62M | ---88.89M | -210.97%-88.89M |
Operating interest expense | ---- | ---- | ---- | -16.05%-1.04B | ---- | ---- | ---- | -24.27%-893.32M | ---408.4M | -15.83%-408.4M |
Special items of operating profit | 15.34%870.6M | -34.81%282.48M | ---- | 240.85%2.13B | 686.38%754.81M | 118.33%433.33M | ---- | -44.66%625.25M | --95.99M | -66.00%198.47M |
Operating profit | 8,513.20%5.31B | 606.03%2.68B | 106.74%87.68M | 300.10%1.6B | 104.34%61.62M | 59.49%-530.03M | -48.69%-1.3B | 94.85%-801.14M | -1.42B | 91.36%-1.31B |
Financing income | 5.26%719.93M | 5.26%719.93M | ---- | ---- | --683.98M | --683.98M | ---- | ---- | ---- | ---- |
Financing cost | 4.95%-514.82M | 4.95%-514.82M | ---- | ---- | ---541.63M | ---541.63M | ---- | ---- | ---- | ---- |
Share of profits of associates | -63.73%1.99M | -63.73%1.99M | ---- | 221.62%15.85M | 138.23%5.48M | 138.23%5.48M | ---- | 64.55%-13.04M | ---14.32M | 13.72%-14.32M |
Special items of earning before tax | ---- | ---- | 9.58%315.42M | ---- | ---- | ---- | 167.66%287.84M | ---- | ---- | ---- |
Earning before tax | 2,533.00%5.51B | 855.92%2.89B | 139.79%403.1M | 298.84%1.62B | 114.60%209.44M | 71.11%-382.21M | 22.10%-1.01B | 94.78%-814.18M | -1.43B | 91.28%-1.32B |
Tax | -76.92%-502.49M | -119.45%-321.85M | -238.65%-80.79M | -63.60%-451.72M | -92.59%-284.02M | -32.45%-146.66M | 52.13%-23.86M | -357.34%-276.11M | ---147.48M | -109.67%-110.73M |
After-tax profit from continuing operations | 6,821.04%5.01B | 585.44%2.57B | 131.09%322.31M | 207.05%1.17B | 95.29%-74.57M | 63.11%-528.87M | 23.20%-1.04B | 93.04%-1.09B | -1.58B | 90.58%-1.43B |
Earning after tax | 6,821.04%5.01B | 585.44%2.57B | 131.09%322.31M | 207.05%1.17B | 95.29%-74.57M | 63.11%-528.87M | 23.20%-1.04B | 93.04%-1.09B | -1.58B | 90.58%-1.43B |
Minority profit | 55.96%543.24M | 179.83%303.16M | 274.91%83.88M | 79.75%551M | 108.31%348.33M | 279.33%108.34M | -234.66%-47.95M | 69.15%306.54M | --167.22M | -80.50%28.56M |
Profit attributable to shareholders | 1,156.72%4.47B | 455.33%2.26B | 124.11%238.43M | 144.11%616.19M | 75.83%-422.91M | 56.42%-637.21M | 28.64%-988.88M | 91.18%-1.4B | -1.75B | 90.48%-1.46B |
Basic earnings per share | 460.00%0.36 | 143.48%0.1 | 60.00%-0.1 | 92.79%-0.23 | 93.09%-0.25 | |||||
Diluted earnings per share | 460.00%0.36 | 143.48%0.1 | 60.00%-0.1 | 92.79%-0.23 | 93.09%-0.25 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data